Starget Pharma is an Israeli biotech and healthtech company1 founded in 20191, headquartered in Ness Ziona1.
It has raised $18M across 1 funding round1; the most recent was a Series A round of $18M1, announced Feb 18, 20261.
Founder: Sigal Kalmanson Cusnir (CEO)1.
Funding history
| Round | Announced | Amount | Lead investors |
|---|---|---|---|
| Series A | Feb 18, 2026 | $18M | Ilex Medical |
Founder
Investors
Which Israeli startups are similar to Starget Pharma?
Sources
- 1CTech, Feb 18, 2026. “Israeli biotech Starget secures $18 million Series A to accelerate precision cancer treatments”
How much funding has Starget Pharma raised?
Starget Pharma has raised $18M across 1 funding round.
What was Starget Pharma’s latest funding round?
Starget Pharma’s most recent round was a Series A round of $18M, announced Feb 18, 2026.
Who founded Starget Pharma?
Starget Pharma was founded by Sigal Kalmanson Cusnir.
Who has invested in Starget Pharma?
Investors in Starget Pharma include Ilex Medical, Louisiana Growth Fund and Cancer Focus Fund BRF.
When was Starget Pharma founded?
Starget Pharma was founded in 2019 and is headquartered in Ness Ziona, Israel.